All Issue

2022 Vol.44, Issue 1 Preview Page

Article

30 March 2022. pp. 29-38
Abstract
References
1
Al-Anazi AF, Qureshi VF, Javaid K, Qureshi S (2011) Preventive effects of phytoestrogens against postmenopausal osteoporosis as compared to the available therapeutic choices: an overview. J Nat Sci Biol Med 2:154-163 22346228PMC3276006
2
An J, Yang H, Zhang Q, Liu C, Zhao J, Zhang L, Chen B (2016) Natural products for treatment of osteoporosis: the effects and mechanisms on promoting osteoblast-mediated bone formation. Life Sci 147:46-58 10.1016/j.lfs.2016.01.02426796578
3
Bae MJ, Karadeniz F, Lee SG, Seo Y, Kong CS (2016) Inhibition of MMP-2 and MMP-9 Activities by <italic>Limonium tetragonum</italic> Extract. Prev Nutr Food Sci 21:38-43 10.3746/pnf.2016.21.1.3827069904PMC4827633
4
Bishop GB, Einhorn TA (2007) Current and future clinical applications of bone morphogenetic proteins in orthopaedic trauma surgery. Int Orthop 31:721-727 10.1007/s00264-007-0424-817668207PMC2266667
5
Bone HG, McClung MR, Roux C, Recker RR, Eisman JA, Verbruggen N, Hustad CM, Da Silva C, Santora AC, Ince BA (2009) Odanacatib, a cathepsin-K inhibitor for osteoporosis: a two-year study in postmenopausal women with low bone density. J Bone Miner Res 25:34-41
6
Colaianni G, Brunetti G, Faienza MF, Colucci S, Grano M (2014) Osteoporosis and obesity: role of Wnt pathway in human and murine models. World J Orthop 5:242-246 10.5312/wjo.v5.i3.24225035826PMC4095016
7
Golub EE, Boesze-Battaglia K (2007) The role of alkaline phosphatase in mineralization. Curr Opin Orthop 18:444-448 10.1097/BCO.0b013e3282630851
8
Guan M, Yao W, Liu R, Lam KS, Nolta J, Jia J, Panganiban B, Meng L, Zhou P, Shahnazari M, Ritchie RO, Lane NE (2012) Directing mesenchymal stem cells to bone to augment bone formation and increase bone mass. Nat Med 18:456-462 10.1038/nm.266522306732PMC3755884
9
Hu L, Yin C, Zhao F, Ali A, Ma J, Qian A (2018) Mesenchymal stem cells: cell fate decision to osteoblast or adipocyte and application in osteoporosis treatment. Int J Mol Sci 19:360 10.3390/ijms1902036029370110PMC5855582
10
Ing SW, Belury MA (2011) Impact of conjugated linoleic acid on bone physiology: proposed mechanism involving inhibition of adipogenesis. Nutr Rev 69:123-131 10.1111/j.1753-4887.2011.00376.x21348876PMC3814018
11
James AW (2013) Review of signaling pathways governing MSC osteogenic and adipogenic differentiation. Scientifica 2013:684736 10.1155/2013/68473624416618PMC3874981
12
Jia M, Nie Y, Cao DP, Xue YY, Wang JS, Zhao L, Rahman K, Zhang QY, Qin LP (2012) Potential antiosteoporotic agents from plants: a comprehensive review. Evid-Based Compl Alt 2012:364604 10.1155/2012/36460423365596PMC3551255
13
Justesen J, Stenderup K, Ebbesen EN, Mosekilde L, Steiniche T, Kassem M (2001) Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology 2:165-171 10.1023/A:101151322389411708718
14
Karadeniz F, Kim JA, Ahn BN, Kwon MS, Kong CS (2014) Effect of Salicornia herbacea on osteoblastogenesis and adipogenesis in vitro. Mar Drugs 12:5132-5147 10.3390/md1210513225310765PMC4210889
15
Kawai M, Rosen CJ (2010) PPARγ: a circadian transcription factor in adipogenesis and osteogenesis. Nat Rev Endocrinol 6:629-636 10.1038/nrendo.2010.15520820194PMC3132113
16
Komm BS, Chines AA (2012) An update on selective estrogen receptor modulators for the prevention and treatment of osteoporosis. Maturitas 71:221-226 10.1016/j.maturitas.2011.11.01822196312
17
Kraenzlin ME, Meier C (2011) Parathyroid hormone analogues in the treatment of osteoporosis. Nat Rev Endocrinol 7: 647-656 10.1038/nrendo.2011.10821750510
18
Lecka-Czernik B (2010) PPARs in bone: the role in bone cell differentiation and regulation of energy metabolism. Curr Osteoporos Rep 8:84-90 10.1007/s11914-010-0016-120425615
19
Lee JI, Kong CS, Jung ME, Hong JW, Noh I, Seo Y (2011) Peroxynitrite-scavenging activity of the halophyte Limonium tetragonum. Ocean Polar Res 33:185-191 10.4217/OPR.2011.33.2.185
20
Matsubara T, Kida K, Yamaguchi A, Hata K, Ichida F, Meguro H, Aburatani H, Nishimura R, Yoneda T (2008) BMP2 regulates Osterix through Msx2 and Runx2 during osteoblast differentiation. J Biol Chem 283:29119-29125 10.1074/jbc.M80177420018703512PMC2662012
21
Ominsky MS, Li C, Li X, Tan HL, Lee E, Barrero M, Asuncion FJ, Dwyer D, Han CY, Vlasseros F, Samadfam R, Jolette J, Smith SY, Stolina M, Lacey DL, Simonet WS, Paszty C, Li G, Ke HZ (2011) Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones. J Bone Miner Res 26:1012-1021 10.1002/jbmr.30721542004
22
Otto S, Sotlar K, Ehrenfeld M, Pautke C (2011) Osteonecrosis of the jaw as a possible rare side effect of annual bisphosphonate administration for osteoporosis: a case report. J Med Case Rep 5:477 10.1186/1752-1947-5-47721943059PMC3195106
23
Rizzoli R, Cooper C, Reginster JY, Abrahamsen B, Adachi JD, Brandi ML, Bruyere O, Compston J, Ducy P, Ferrari S, Harvey NC, Kanis JA, Karsenty G, Laslop A, Rabenda V, Vestergaard P (2012) Antidepressant medications and osteoporosis. Bone 51:606-613 10.1016/j.bone.2012.05.01822659406
24
Veronesi F, Torricelli P, Borsari V, Tschon M, Rimondini L, Fini M (2011) Mesenchymal stem cells in the aging and osteoporotic population. Crit Rev Eukar Gene 21:363-377 10.1615/CritRevEukarGeneExpr.v21.i4.6022181705
25
Wan Y, Chong LW, Evans RM (2007) PPAR-γ regulates osteoclastogenesis in mice. Nat Med 13:1496-1503 10.1038/nm167218059282
26
Wang C, Meng H, Wang X, Zhao C, Peng J, Wang Y (2016) Differentiation of bone marrow mesenchymal stem cells in osteoblasts and adipocytes and its role in treatment of osteoporosis. Med Sci Monit 22:226-233 10.12659/MSM.89704426795027PMC4727494
27
Watts NB, Diab DL (2010) Long-term use of bisphosphonates in osteoporosis. J Clin Endocrinol Metab 95:1555-1565 10.1210/jc.2009-194720173017
28
Woo C, Gao G, Wade S, Hochberg MC (2010) Gastrointestinal side effects in postmenopausal women using osteoporosis therapy: 1-year findings in the POSSIBLE US study. Curr Med Res Opin 26:1003-1009 10.1185/0300799100363360320201623
29
Xu C, Wang J, Zhu T, Shen Y, Tang X, Fang L, Xu Y (2016) Cross-talking between PPAR and WNT signaling and its regulation in mesenchymal stem cell differentiation. Curr Stem Cell Res Ther 11:247-254 10.2174/1574888X1066615072314570726201865
30
Yang MH, Kim NH, Heo JD, Sung SH, Jeong EJ (2014) Hepatoprotective effects of Limonium tetragonum, edible medicinal halophyte growing near seashores. Pharmacogn Mag 10: S563-S568 10.4103/0973-1296.13978325298675PMC4189273
31
Zhou BO, Yue R, Murphy MM, Peyer JG, Morrison SJ (2014) Leptin-receptor- expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow. Cell Stem Cell 15:154-168 10.1016/j.stem.2014.06.00824953181PMC4127103
32
Zhuang H, Zhang X, Zhu C, Tang X, Yu F, Shang WG, Cai X (2016) Molecular mechanisms of PPAR-γ; governing MSC osteogenic and adipogenic differentiation. Curr Stem Cell Res Ther 11:255-264 10.2174/1574888X1066615053117330926027680
Information
  • Publisher :Korea Institute of Ocean Science and Technology
  • Publisher(Ko) :한국해양과학기술원
  • Journal Title :Ocean and Polar Research
  • Journal Title(Ko) :Ocean and Polar Research
  • Volume : 44
  • No :1
  • Pages :29-38
  • Received Date :2021. 12. 01
  • Revised Date :2021. 12. 30
  • Accepted Date : 2022. 01. 09